Monitor future Form 4 filings for insider transactions that may signal management's view on valuation. This initial filing is a baseline — no trading signal.
Price Chart
Executive Summary
Zhen Li, Ph.D., the President and CEO of ADARx Pharmaceuticals, filed a Form 3 initial statement of beneficial ownership, disclosing 5,861,199 shares of common stock held via a trust and substantial employee stock options. This is a routine filing required upon becoming an insider and provides no new information about the company's operations or financial performance.
Key Facts
- Zhen Li, Ph.D., President and CEO, filed Form 3 on 2026-09-24.
- Beneficially owns 5,861,199 shares of common stock held via the Titanium Boulder Irrevocable Trust.
- Holds employee stock options to purchase 5,457,534 shares of common stock directly, with exercise prices ranging from $0.24 to $7.05 and expiration dates from 2030 to 2036.
- Spouse holds options to purchase 54,272 shares indirectly.
- No market transactions reported; filing is administrative in nature.
Financial Impact
No financial impact; filing discloses existing holdings only.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001729510-26-000004 |
| Document: 0001729510-26-000004-index-headers.html | 0001729510-26-000004 |
| Document: 0001729510-26-000004-index.html | 0001729510-26-000004 |
| Document: 0001729510-26-000004.txt | 0001729510-26-000004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | SC 13G | $17.63 $17.68 | ▲ +0.28% | ▼ −0.05% | $17.81 (+1.02%) |
Oct 5, 2026 21d ago | SC 13D | $18.58 $17.33 | ▼ −6.73% | ▼ −6.49% | $17.81 (−4.14%) |
Oct 2, 2026 24d ago | SC 13D | $19.05 $18.58 | ▼ −2.47% | ▼ −3.02% | $17.81 (−6.51%) |
Oct 1, 2026 25d ago | Press Release | $18.25 $19.05 | ▲ +4.38% | ▲ +3.71% | $17.81 (−2.41%) |
Oct 1, 2026 25d ago | SC 13G | $18.25 $19.05 | ▲ +4.38% | ▲ +3.71% | $17.81 (−2.41%) |
Sep 30, 2026 26d ago | Insider Cluster | $19.54 $18.25 | ▼ −6.60% | ▼ −7.34% | $17.81 (−8.85%) |
Sep 29, 2026 27d ago | Insider Cluster | $19.94 $19.54 | ▼ −2.01% | ▼ −2.18% | $17.81 (−10.68%) |
Sep 25, 2026 4w ago | 424B4 | $20.09 $20.64 | ▲ +2.71% | ▲ +2.90% | $17.81 (−11.35%) |
Sep 25, 2026 4w ago | EFFECT | $19.35 $20.09 | ▲ +3.82% | ▲ +4.57% | $17.81 (−7.96%) |
Sep 24, 2026 4w ago | Press Release | $19.35 $20.09 | ▲ +3.82% | ▲ +4.57% | $17.81 (−7.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers